Evaluation of Cell Models to Study Monocyte Functions in PMM2 Congenital Disorders of Glycosylation.

Front Immunol · 2022 · PMC9121068 · PMID 35603178

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

We found a highly significant decrease in PMM2 enzymatic activity that went from 2.62 mU/mg in the non-targeting (NT) control cells to 0.37 mU/mg in PMM2 knockdown cells.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.